Drugs / MK-0634
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00231790 | Aug 2005 → Sep 2006 | overactive bladder | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MK-0634 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00231790 ↗ |
| Route | Oral | “one capsule orally, once daily in morning” NCT00231790 ↗ |